ZynexZYXI
About: Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Employees: 1,000
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
1.44% less ownership
Funds ownership: 26.8% [Q3] → 25.36% (-1.44%) [Q4]
4% less funds holding
Funds holding: 100 [Q3] → 96 (-4) [Q4]
7% less capital invested
Capital invested by funds: $69.4M [Q3] → $64.7M (-$4.71M) [Q4]
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
24% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 34
67% less call options, than puts
Call options by funds: $25K | Put options by funds: $76K
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
RBC Capital Shagun Singh 33% 1-year accuracy 22 / 66 met price target | 158%upside $5.50 | Sector Perform Downgraded | 12 Mar 2025 |
HC Wainwright & Co. Yi Chen 28% 1-year accuracy 48 / 172 met price target | 604%upside $15 | Buy Maintained | 12 Mar 2025 |
Financial journalist opinion
Based on 332 articles about ZYXI published over the past 30 days









